Rayyan Therapeutics is a biotech company focused on revolutionizing stroke care through the development of novel therapeutic solutions. Our mission is to address the critical unmet needs in stroke treatment by extending intervention windows and improving patient outcomes. By leveraging innovative research and strategic collaborations with academic institutions and industry leaders, we aim to create therapies that redefine the standard of care for stroke patients.
With a commitment to advancing science and a patient-centered approach, Rayyan Therapeutics is dedicated to transforming lives affected by stroke. Our work is driven by the urgency to provide effective, accessible solutions that reduce the devastating impact of stroke on individuals, families, and healthcare systems worldwide.